Terns PharmaceuticalsTERN
13F holders, Q2 2026 (June 30)1holders −316
0new positions
313sold out
$52.95avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Terns Pharmaceuticals Inc. (TERN) in their 13F filings, down 316 from Q1 2026. 0 opened new positions and 313 sold out. The largest holder was IFP Advisors, Inc ($75K).
- Company
- Terns Pharmaceuticals Inc.
- CUSIP
- 880881107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 313 | $6.5B |
All 13F filers, Q1 2026 → Q2 2026: 123,142,502 shares sold, net −123,142,502 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 1,424 | $75K |
"% of holder's portfolio" is TERN's weight in each manager's 13F, not the share of Terns Pharmaceuticals Inc. the manager owns.